Looks like you have JavaScript disabled. For the full Twine experience, you will need to re-enable it.

I am an experienced scientific and medical writer with a strong background in biomedical research and clinical development. I specialize in translating complex scientific data into clear, compelling content for diverse audiences such as regulatory agencies, healthcare professionals, and investors. Over the years, I've worked on a wide range of documents including clinical trial protocols, regulatory submissions, and medical education materials. As a Senior Scientist and Project Manager, I have led cross-functional teams and secured significant funding while ensuring timely delivery of high-quality work. I'm passionate about advancing translational research and enjoy collaborating with experts to bring innovative therapies into clinical practice.…I am an experienced scientific and medical writer with a strong background in biomedical research and clinical development. I specialize in translating complex scientific data into clear, compelling content for diverse audiences such as regulatory agencies, healthcare professionals, and investors. Over the years, I've worked on a wide range of documents including clinical trial protocols, regulatory submissions, and medical education materials. As a Senior Scientist and Project Manager, I have led cross-functional teams and secured significant funding while ensuring timely delivery of high-quality work. I'm passionate about advancing translational research and enjoy collaborating with experts to bring innovative therapies into clinical practice.

Gopalakrishnan Ramakrishnan





I am an experienced scientific and medical writer with a strong background in biomedical research and clinical development. I specialize in translating complex scientific data into clear, compelling content for diverse audiences such as regulatory agencies, healthcare professionals, and investors. Over the years, I've worked on a wide range of documents including clinical trial protocols, regulatory submissions, and medical education materials. As a Senior Scientist and Project Manager, I have led cross-functional teams and secured significant funding while ensuring timely delivery of high-quality work. I'm passionate about advancing translational research and enjoy collaborating with experts to bring innovative therapies into clinical practice.…I am an experienced scientific and medical writer with a strong background in biomedical research and clinical development. I specialize in translating complex scientific data into clear, compelling content for diverse audiences such as regulatory agencies, healthcare professionals, and investors. Over the years, I've worked on a wide range of documents including clinical trial protocols, regulatory submissions, and medical education materials. As a Senior Scientist and Project Manager, I have led cross-functional teams and secured significant funding while ensuring timely delivery of high-quality work. I'm passionate about advancing translational research and enjoy collaborating with experts to bring innovative therapies into clinical practice.

Available to hire

I am an experienced scientific and medical writer with a strong background in biomedical research and clinical development. I specialize in translating complex scientific data into clear, compelling content for diverse audiences such as regulatory agencies, healthcare professionals, and investors. Over the years, I’ve worked on a wide range of documents including clinical trial protocols, regulatory submissions, and medical education materials.

As a Senior Scientist and Project Manager, I have led cross-functional teams and secured significant funding while ensuring timely delivery of high-quality work. I’m passionate about advancing translational research and enjoy collaborating with experts to bring innovative therapies into clinical practice.

Skills

Experience Level

Expert

Intermediate

Beginner

Beginner

Beginner

Work Experience

Senior Scientist and Project Manager at Targazyme Inc.

January 1, 2021 - Present

Involved in protocol preparation, submission, and securing FDA concurrence for Phase 2/3 registration trials. Led label expansion processes in cancer, autoimmune diseases, and non-malignant blood disorders. Secured non-dilutive SBIR and foundation funding, co-led Series B investor due diligence, and prepared regulatory documentation for IND and CMC. Directed cross-functional teams across R&D, regulatory, and GMP manufacturing to align clinical timelines.

R&D Scientist at ShieldT3 LLC

December 31, 2023 - July 17, 2025

Spearheaded novel diagnostic, detection, and screening assays from biological and wastewater samples for surveillance and epidemiology. Oversaw restructuring from human disease to animal disease testing post-pandemic. Led switch to wastewater-based assays over biological samples, significantly reducing sample collection and testing costs.

Research Assistant Professor at University of Illinois at Chicago

December 31, 2022 - July 17, 2025

Discovered new signalling network involving Hexokinase2 in cancer and metastasis, establishing HK2 as a unique cancer-specific therapeutic target. Supervised studies on small molecule inhibitors for HK2. Developed inducible transgenic and PDX mouse models for in vivo validation. Identified AKT1 as a specific target in metastasis and resistance mechanisms to AKT inhibitors in clinical trials.

Post Doctoral Fellow at Cancer Institute, Univ. Of Mississippi Medical Centre

December 31, 2017 - July 17, 2025

Identified NF1 as a novel driver alteration in lung and pancreatic cancers. Discovered a novel TGIF-YAP1 signalling axis in lung and colorectal cancer. Identified transcriptional targets of mutant p53 regulating nucleotide metabolism. Uncovered signalling network involving mutant p53, RasaL2, and NFkB in cancer inflammation. Identified unique phosphorylation sites on Notch4 and Sirt2, developing phospho-specific antibodies. Explored role of NAD in longevity, metabolic resistance, and stress-induced cell death.

Senior Scientist and Project Manager at Targazyme Inc.

January 1, 2021 - Present

Involved in the protocol preparation, submission and FDA concurrence for Phase 2/3 registration trials. Led label expansion process with new pipelines in cancer, autoimmune diseases, and non-malignant blood disorders. Secured non-dilutive SBIR and foundation funding, co-led Series B investor due diligence, and prepared regulatory documentation for IND and CMC. Directed cross-functional teams across R&D, regulatory, and GMP manufacturing to align clinical timelines.

R&D Scientist at ShieldT3 LLC

December 31, 2023 - July 22, 2025

Spearheaded novel diagnostic, detection and screening assays from biological and wastewater samples for surveillance and epidemiology. Oversaw the restructuring from human disease to animal disease testing post the decline in pandemic related testing. Led switch to wastewater-based assays over biological samples, immensely saving on sample collection and testing.

Research Assistant Professor at University of Illinois at Chicago

December 31, 2022 - July 22, 2025

Discovered new signalling network involving Hexokinase2 in cancer and metastasis establishing HK2 as a unique cancer specific target for therapy. Supervised study for a small molecule inhibitor for HK2 using a GSK3 phosphorylation-based screen. Developed novel inducible transgenic and PDX mouse models for in vivo validation. Identified AKT1 as a specific target in metastasis and observed resistance to AKT inhibitors in clinical trials.

Post Doctoral Fellow at Cancer Institute, Univ. Of Mississippi Medical Centre

December 31, 2017 - July 22, 2025

Identified NF1 as a novel driving alteration in lung and pancreatic cancers. Discovered TGIF-YAP1 signalling axis in Lung and Colorectal Cancer development. Identified novel transcriptional targets of mutant p53 regulating nucleotide metabolism. Uncovered mutant p53-RasaL2 and NFkB complex signaling network regulating inflammation in cancer. Developed phospho-specific antibodies for unique phosphorylation sites on Notch4 and Sirt2. Studied NAD’s role in longevity, calorie resistance and stress-induced cell death.

Freelance Scientific and Medical Writer at Upwork

January 1, 2020 - Present

Providing freelance scientific and medical writing services including manuscript development, grant writing, regulatory documents, and medical communications to clients across academic, biotech, and clinical settings.